Search for: "Market Solutions Limited Inc." Results 681 - 700 of 1,463
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2017, 9:54 am by Dennis Crouch
”   In other words: is the hydrophilic matrix limited only to substances in the list. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
Pharmatech Solutions, Inc., No. 16-377 Claim Construction: Google, Inc. v. [read post]
6 Feb 2017, 4:57 am
Black, White, and Green: Farmers Markets, Race, and the Green Economy. [read post]
23 Jan 2017, 2:47 pm by Cynthia Marcotte Stamer
 One obvious place where statutory limitations on Agencies authority almost certainly will impact the availability of relief arises from the ACA’s incorporation of many of its patient protection act group mandates into ERISA. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Pharmatech Solutions, Inc., No. 16-377 Claim Construction: Google, Inc. v. [read post]
13 Jan 2017, 9:53 am by Eric Citron
These cases are  American Atheists Inc. v. [read post]
In some cases, it may be useful to engage a third party to provide technological assistance with opt-out solutions for in-app advertising. [read post]
26 Dec 2016, 4:30 am by Ben
Well Marie-Andree cited that 1879 case  Feist Publications, Inc. v. [read post]
21 Nov 2016, 5:56 pm by Cynthia Marcotte Stamer
  While federal tax rules afford some evidentiary privileges to certain accounting professionals when providing tax representation or advice, the protective scope of such privileges generally are more limited than attorney-client privilege and work product evidentiary privileges and typically do not apply to non-tax matters. [read post]
20 Nov 2016, 6:10 pm by Kevin O'Keefe
Doing so they could be vendor-locking themselves into often outdated/expansive software and limited and expensive future upgrades. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
Pharmatech Solutions, Inc., No. 16-377 Design Patents: Systems, Inc. v. [read post]
1 Nov 2016, 4:00 am by Malcolm Mercer
Said another way, the market for legal services is constrained by limiting the supply side thereby causing unmet demand. [read post]
31 Oct 2016, 11:33 am
At issue is Plaintiffs' transdermal testosterone solution, which is marketed under the trade name "Axiron®. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
Pharmatech Solutions, Inc., No. 16-377 Post Grant Admin: Cooper v. [read post]